Image (IMAGE)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)

Image

Caption

Active mitochondria are needed for optimal anti-tumor immunotherapy with cDC1s. While control cDC1 vaccine is effective in reducing the metastasis of intravenously injected B16-OVA tumors, the cDC1s with impaired mitochondria show less effective cancer immunotherapy.

Credit

CNIC

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.